Barclays Starts Terns Pharmaceuticals (TERN) at Overweight
Tweet Send to a Friend
(Updated - September 17, 2025 4:37 AM EDT)
Barclays analyst Etzer Darout initiates coverage on Terns Pharmaceuticals (NASDAQ: TERN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst Etzer Darout initiates coverage on Terns Pharmaceuticals (NASDAQ: TERN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


